Skip to main content
DutyStation
📰 GeneralCNBCMonday, September 21, 2026 at 4:59 PM UTC50m ago

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation News.

📰 Related Stories

Xiaomi 18 Pro has a Privacy Display that does more than Galaxy S26 Ultra, launches this week [Video]
📰 General

Xiaomi 18 Pro has a Privacy Display that does more than Galaxy S26 Ultra, launches this week [Video]

9to5Google24m ago
📰 General

Stock boom is fueling a ‘retirement party,’ economists say — what it means for workers

CNBC35m ago
📰 General

Oura’s $2.2B IPO is mostly a payday for existing shareholders

TechCrunch1h ago
Russel Vought will reportedly be given veto power over all NIH grants
📰 General

Russel Vought will reportedly be given veto power over all NIH grants

Ars Technica1h ago
📰 General

With Tabby, a former accountant is using AI to make accountants obsolete

TechCrunch1h ago
Bungie says it’s ‘not done with Destiny’ and will bring back vaulted content
📰 General

Bungie says it’s ‘not done with Destiny’ and will bring back vaulted content

The Verge1h ago
← Back to News